Olanzapin (Q201872)

reaktant

1 referanse

importert fra Wikimedia-prosjekt

Gene Ontology release 2019-11-16 ^engelsk

1 referanse

Olanzapine (engelsk)

17. nov. 2015

Olanzapine Structural Formulea V.2.svg
450 × 414; 18 KB

1 referanse

Wikipedia på tysk

Olanzapine.svg
512 × 523; 6 KB

0 referanser

masse

312,1409 atommasseenhet

1 referanse

ChEMBL ^{norsk nynorsk}

OLANZAPINE (engelsk)

18. nov. 2016

olanzapine tautomer ^engelsk

0 referanser

kjemisk formel

C₁₇H₂₀N₄S

1 referanse

olanzapine (engelsk)

16. sep. 2016

CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C

1 referanse

olanzapine (engelsk)

18. nov. 2016

forordnet daglig dose

10 milligram

administrasjonsvei

peroral terapi

1 referanse

https://www.whocc.no/atc_ddd_index/?code=N05AH03

10 milligram

administrasjonsvei

parenteral administrasjonsvei

1 referanse

https://www.whocc.no/atc_ddd_index/?code=N05AH03

aktiv bestanddel i

Olansek ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/000114

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000114/human_med_000942.jsp

22. mar. 2017

Olanzapine Apotex ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/001178

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001178/human_med_001345.jsp

22. mar. 2017

Olanzapine Cipla ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/000793

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000793/human_med_000944.jsp

22. mar. 2017

Olanzapine Glenmark ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/001085

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001085/human_med_001302.jsp

22. mar. 2017

Olanzapine Glenmark Europe ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/001086

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001086/human_med_001303.jsp

22. mar. 2017

Olanzapine Mylan ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/000961

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000961/human_med_000943.jsp

22. mar. 2017

Olanzapine Teva ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/000810

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000810/human_med_000945.jsp

22. mar. 2017

Olazax ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/001087

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001087/human_med_001304.jsp

22. mar. 2017

Olazax Disperzi ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/001088

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001088/human_med_001305.jsp

22. mar. 2017

Zalasta ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/000792

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000792/human_med_001168.jsp

22. mar. 2017

Zyprexa ^engelsk

1 referanse

RxNorm ^engelsk

RxNorm CUI ^{norsk nynorsk}

135423

14. feb. 2018

Zyprexa Velotab ^engelsk

1 referanse

EMA-identifikator ^{norsk nynorsk}

EMEA/H/C/000287

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000287/human_med_001190.jsp

22. mar. 2017

1 referanse

13. des. 2016

schizofreniform lidelse

1 referanse

13. des. 2016

1 referanse

13. des. 2016

1 referanse

2. okt. 2018

psykisk lidelse

1 referanse

2. okt. 2018

Affektive lidelser

1 referanse

2. okt. 2018

psykose

1 referanse

2. okt. 2018

søvnløshet

1 referanse

2. okt. 2018

tvangslidelse

1 referanse

2. okt. 2018

angst

1 referanse

2. okt. 2018

schizoaffektiv lidelse

1 referanse

2. okt. 2018

angstlidelse

1 referanse

2. okt. 2018

sleep-wake disorder ^engelsk

1 referanse

signifikant legemiddelinteraksjon med

2. okt. 2018

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

klozapin

beinmergssvikt ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

aripiprazol ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

sotalol ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

klonidin ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

zuclopenthixol ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

periciazine ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

sulpirid ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

levodopa ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

sotalol ^{norsk nynorsk}

torsades de pointes ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

zuclopenthixol ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

aripiprazol ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

sulpirid ^{norsk nynorsk}

torsades de pointes ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

sulpirid ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

periciazine ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

tramadol ^{norsk nynorsk}

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

tramadol ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

tramadol ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

Morfin

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

Morfin

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

Morfin

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

hydromorfon

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

hydromorfon

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

hydromorfon

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

fentanyl

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

fentanyl

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

fentanyl

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

dihydrokodein ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

dihydrokodein ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

Kodein

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

Kodein

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

metadon

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

metadon

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

metadon

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

oksykodon

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

oksykodon

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

oksykodon

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

buprenorfin

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

buprenorfin

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

buprenorfin

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

petidin

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

petidin

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

petidin

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

tapentadol ^engelsk

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

tapentadol ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

tapentadol ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

sufentanil ^engelsk

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

sufentanil ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

sufentanil ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

alfentanil ^engelsk

paralytic ileus ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

alfentanil ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

alfentanil ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

klonidin ^{norsk nynorsk}

ortostatisk intoleranse ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

loksapin

kognitiv forstyrring ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

loksapin

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

loksapin

sedering ^{norsk nynorsk}

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

Haloperidol

tannhjulsrigiditet ^{norsk nynorsk}

1 referanse

sannsynlig

5-hydroksytryptaminreseptor 1A

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

1 referanse

A reference set of clinically relevant adverse drug-drug interactions ^engelsk

reagerer fysisk med

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

5-hydroksytryptaminreseptor 1B ^{norsk nynorsk}

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

5-hydroksytryptaminreseptor 1D ^{norsk nynorsk}

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

5-hydroksytryptaminreseptor 1E ^{norsk nynorsk}

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

5-hydroksytryptaminreseptor 1F ^{norsk nynorsk}

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

5-hydroksytryptaminreseptor 2A ^{norsk nynorsk}

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

5-hydroksytryptaminreseptor 2C ^{norsk nynorsk}

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

5-hydroksytryptaminreseptor 6 ^{norsk nynorsk}

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

5-hydroksytryptaminreseptor 7 ^{norsk nynorsk}

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

dopamin-D2-reseptor ^{norsk nynorsk}

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

histamin H1-reseptor ^{norsk nynorsk}

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

17. aug. 2016

boxed warning ^engelsk

1 referanse

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

tittel

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (engelsk)

risikokategori for svangerskap

Australian pregnancy category C ^{norsk nynorsk}

1 referanse

importert fra Wikimedia-prosjekt

Wikipedia på engelsk

US pregnancy category C ^{norsk nynorsk}

1 referanse

importert fra Wikimedia-prosjekt

Wikipedia på engelsk

selektiv serotoninreopptakshemmer

muskarinantagonist ^{norsk nynorsk}

1 referanse

5. mar. 2018

α-blokkar ^{norsk nynorsk}

1 referanse

5. mar. 2018

H1-antagonist ^{norsk nynorsk}

1 referanse

5. mar. 2018

serotoninantagonist ^{norsk nynorsk}

1 referanse

5. mar. 2018

dopaminantagonist ^{norsk nynorsk}

1 referanse

5. mar. 2018

1 referanse

5. mar. 2018

1 referanse

15. mar. 2018

1 referanse

15. mar. 2018

1 referanse

15. mar. 2018

OLANZapine

Tall Man lettering ^engelsk

forvaltet av

Institute for Safe Medication Practices ^engelsk

1 referanse

https://www.ismp.org/recommendations/tall-man-letters-list

2. sep. 2022

ZyPREXA

har egenskap

Tall Man lettering ^engelsk

forvaltet av

Institute for Safe Medication Practices ^engelsk

1 referanse

https://www.ismp.org/recommendations/tall-man-letters-list

2. sep. 2022

0 referanser

0 referanser

Olanzapine

0 referanser

Identifikatorer

BNE-identifikator

XX542695

0 referanser

InChI

InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3

1 referanse

olanzapine (engelsk)

18. nov. 2016

2 referanser

olanzapine (engelsk)

18. nov. 2016

ChEBI release 2020-09-01 ^engelsk

CAS-nummer

132539-06-1

2 referanser

olanzapine (engelsk)

18. nov. 2016

CAS Common Chemistry ^engelsk

10. apr. 2021

https://commonchemistry.cas.org/detail?cas_rn=132539-06-1

1 referanse

Olanzapine (engelsk)

18. nov. 2016

cannot be confirmed by other sources ^engelsk

0 referanser

135398745

1 referanse

Reaxys-nummer ^{norsk nynorsk}

7655141

1 referanse

olanzapine (engelsk)

3. okt. 2016

2 referanser

ChEMBL ^{norsk nynorsk}

OLANZAPINE (engelsk)

18. nov. 2016

InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3

International Chemical Identifier ^{norsk nynorsk}

InChI

ChEMBL-ID

CHEMBL715

1 referanse

basert på følgende heuristikk

ChEMBL ^{norsk nynorsk}

OLANZAPINE (engelsk)

18. nov. 2016

SureChEMBL ID ^engelsk

SCHEMBL28763

2 referanser

inferred from InChIKey ^engelsk

UniChem compound ID ^engelsk

27240

1 referanse

MSBNK-Athens_Univ-AU151701

UniChem ^engelsk

MassBank accession ID ^engelsk

0 referanser

MSBNK-Athens_Univ-AU151702

0 referanser

MSBNK-Athens_Univ-AU151703

0 referanser

MSBNK-Athens_Univ-AU151704

0 referanser

MSBNK-Athens_Univ-AU151705

0 referanser

MSBNK-Athens_Univ-AU151707

0 referanser

MSBNK-Athens_Univ-AU151708

0 referanser

MSBNK-Athens_Univ-AU151709

0 referanser

MSBNK-Athens_Univ-AU151710

0 referanser

MSBNK-Athens_Univ-AU151711

0 referanser

MSBNK-Athens_Univ-AU151730

0 referanser

MSBNK-Athens_Univ-AU151731

0 referanser

MSBNK-Athens_Univ-AU151732

0 referanser

MSBNK-Waters-WA002210

0 referanser

MSBNK-Waters-WA002211

0 referanser

MSBNK-Waters-WA002212

0 referanser

MSBNK-Waters-WA002213

0 referanser

MSBNK-Waters-WA002214

0 referanser

SPLASH-id ^{norsk nynorsk}

splash10-03di-0049000000-83ee647255e8d18f2b5c

0 referanser

splash10-0a4i-0090000000-81810b42dccae4ee9ab6

0 referanser

splash10-0bt9-0490000000-8994262c6a309d663713

0 referanser

splash10-01ot-0950000000-ceb0ca01cefbd1da57d7

0 referanser

splash10-03di-0149000000-e74851873e2fbaa6c182

0 referanser

splash10-03dj-0940000000-1103f40c5bb833e12903

0 referanser

NMRShiftDB structure ID ^engelsk

10021706

1 referanse

HSDB ID ^engelsk

8155

1 referanse

Hazardous Substances Data Bank ^engelsk

HSDB ID ^engelsk

28. okt. 2019

Olanzapine (engelsk)

10. mai 2021

DSSTOX-stoffidentifikator ^{norsk nynorsk}

DTXSID9023388

2 referanser

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^engelsk

DSSTOX compound identifier ^engelsk

DTXCID503388

0 referanser

EU-nummer

603-618-4

1 referanse

ECHA-databasen ^{norsk nynorsk}

ECHA InfoCard-id ^{norsk nynorsk}

100.125.320

27. des. 2018

tittel

10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)- (engelsk)

sitat

CAS no.: 132539-06-1 (engelsk)

ECHA InfoCard-id ^{norsk nynorsk}

100.125.320

1 referanse

ECHA-databasen ^{norsk nynorsk}

ECHA InfoCard-id ^{norsk nynorsk}

100.125.320

27. des. 2018

tittel

10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)- (engelsk)

sitat

CAS no.: 132539-06-1 (engelsk)

1 referanse

Olanzapine (engelsk)

17. nov. 2015

1 referanse

IUPHAR/BPS Guide to PHARMACOLOGY ^{norsk nynorsk}

olanzapine (engelsk)

16. sep. 2016

Olanzapine

0 referanser

MeSH-kode

D03.633.100.079.080.738

0 referanser

RxNorm CUI ^{norsk nynorsk}

61381

1 referanse

olanzapine (engelsk)

18. nov. 2016

1 referanse

basert på følgende heuristikk

HMDB-ID

HMDB0005012

2 referanser

inferred from InChIKey ^engelsk

UNII

N7U69T4SZR

2 referanser

olanzapine (engelsk)

18. nov. 2016

MedlinePlus drug identifier ^engelsk

0 referanser

intramuskulær injeksjon

0 referanser

PatientsLikeMe treatment ID ^engelsk

0 referanser

1 referanse

https://docs.openalex.org/download-snapshot/snapshot-data-format

olanzapine (engelsk)

18. nov. 2016

Probes And Drugs ID ^engelsk

PD000646

0 referanser

DrugCentral ID ^engelsk

1 referanse

UniChem ^engelsk

1 referanse

olanzapine (engelsk)

3. okt. 2016

1 referanse

olanzapine (engelsk)

3. okt. 2016

APA Dictionary of Psychology entry ^engelsk

olanzapine

0 referanser

DeCS ID ^engelsk

0 referanser

1 referanse

Freebase-data fra Google

utgivelsesdato

28. okt. 2013

Microsoft Academic-ID

0 referanser

1 referanse

26. jan. 2022

1 referanse

0 referanser

UK Parliament thesaurus-ID

447916

oppført som

Olanzapine

0 referanser

UMLS CUI

C0171023

1 referanse